Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreUtilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn MoreIQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreThe exciting new IQVIA Prescription Based Services 2.0 is delivered two weeks after period, instead of four. Faster delivery means faster actionable insights.
Panel projection and data modelling enhancements, including a new imputation process, give an improved national and regional view of the UK Pharmaceutical market.
To learn more or for a quick demo, contact AskIQVIA@iqvia.com.
Introducing the revolutionary new prescription-based data service, delivering faster prescription data in just four days
Benchmark performance and plan effectively for new market opportunities
Delivering commercial growth with primary care insights on disease treatment and GP prescribing patterns
Real World Data Insights from UK primary care Electronic Medical Records
Improving brand monitoring and sales force effectiveness in the UK hospital sector
Understand routes of supply to better manage stock, respond to market dynamics and stay ahead of the competition
Enabling 58% of GPs in England to Recommend High Quality Digital Health Apps to Their Patients
Delivered through intuitive modern tools and transformative technology, these solutions enable you to make informed decisions